Riva-Posse, P
Choi, K S
Holtzheimer, P E
Crowell, A L
Garlow, S J
Rajendra, J K
McIntyre, C C
Gross, R E
Mayberg, H S
Article History
Received: 2 September 2016
Revised: 17 February 2017
Accepted: 22 February 2017
First Online: 11 April 2017
Competing interests
: PE Holtzheimer reported serving as a paid consultant to St Jude Medical. RE Gross reported receiving grants from Medtronic, Neuropace and MRI Interventions, honoraria from Medtronic Inc and MRI Interventions; and serving as a paid consultant to St Jude Medical, Medtronic, Neuropace, MRI Intervantions, Neuralstem and SanBio. CC McIntyre is a paid consultant for Boston Scientific Neuromodulation, and is a shareholder in the following companies: Surgical Information Sciences; Autonomic Technologies; Cardionomic; Enspire DBS; Neuros Medical. HS Mayberg has a consulting agreement with St Jude Medical, which has licensed her intellectual property to develop SCC DBS for the treatment of severe depression (US 2005/0033379A1). Medtronic and St Jude Medical Corp develop products related to the research described in this article. The terms of these arrangements have been reviewed and approved by Emory University in accordance with their conflict of interest policies. The remaining authors declare no conflict of interest.